Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Kaleab Alemayehu Zewdie, Brhane Teklebrhan Assefa, Muluken Altaye Ayza Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin TafereDepartment of Pharmacology an...
Guardado en:
Autores principales: | Tafere GG, Wondafrash DZ, Zewdie KA, Assefa BT, Ayza MA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/169c311a190547a9b9cc3b5da5b28bda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
por: Wondafrash DZ, et al.
Publicado: (2020) -
Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus
por: Cheema AK, et al.
Publicado: (2020) -
Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
por: Mussa BM, et al.
Publicado: (2021) -
Research Progress on Gestational Diabetes Mellitus and Endothelial Dysfunction Markers
por: He Y, et al.
Publicado: (2021) -
Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus
por: Zhao H, et al.
Publicado: (2020)